Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' UI element was removed, a minor change.
    Difference
    0.8%
    Check dated 2025-09-15T19:30:10.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-08T15:06:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    5%
    Check dated 2025-09-01T09:40:27.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-18T02:16:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-11T00:13:31.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-03T17:54:21.000Z thumbnail image

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.